Address: Dockplatsen 26 | SE-211 19 Malmö, Sweden
Phone: +46 768 89 06 65
Website: https://www.investinskane.com/
Info:
Invest in Skåne is the official business promotion agency for Sweden’s southernmost region Skåne. We provide professional advice and services to international companies considering Skåne for future investment and assist regional companies in developing their international business.
Invest in Skåne has a dual role:
1. To connect international companies with business opportunities in Southern Sweden
2. To help Swedish companies (in our regions) to internationalise their business.
Doing this strengthens the business competitiveness of our region and that of Southern Swedish companies internationally. To support this aim we provide a one-stop investment consultancy service – free-of-charge.
Invest in Skåne is the official regional business promotion agency for Southern Sweden and provides one-stop investment and export consultancy. Ulrika Ringdahl, managing director, reveals the unique opportunities available in…
Over the past three years, Sanofi has significantly expanded its presence in the GCC region, launching 40-50 new products, including treatments for rare diseases and advancements in immunology, diabetes management,…
Long-established as the Middle East and Africa’s leading country in terms of rapid access to biomedical innovation, the UAE is looking to bolster this positioning in the coming years. Indeed,…
VMS Group was founded in 2006 and since then has built close relationships with a handful of large anchor investors, including some of the largest families in Hong Kong. Apart…
Since it was established in 1988, PhIRDA, an organization that groups together China’s pharma innovators, research institutions and investors has played an active role in the evolution of China’s biopharma…
Prof. Song Ruilin outlines the Chinese (bio)pharmaceutical industry’s progress across the three key pillars of innovation, industrialization, and internationalization in recent years. While a downturn in the global economy and…
Regular contributor Brendan Shaw gives his informed take on how best international stakeholders can engage with India’s attempts to transform into a global pharma innovation powerhouse, Our greatest ability…
Dr Viranchi Shah of Saga Lifesciences and the Indian Drug Manufacturers Association (IDMA) outlines the Indian pharmaceutical industry’s potential for growth and its role in global health initiatives. He highlights…
Dr Dalia Samra-Rothe highlights the role of AHK in facilitating German companies’ entry into the Saudi market, the significant economic transformation and opportunities in Saudi Arabia, and the importance of…
Multinational life science firms have been present in India for decades. However, they have often eschewed bringing their latest products to a country that has long prioritised affordability above innovation.…
The State of Gujarat is one of India’s most culturally diverse, the birthplace of ‘Father of the Nation’ Mahatma Gandhi, and the only place in the world where Asiatic lions…
As the GCC’s largest market, Saudi Arabia, with its growing population, strong healthcare infrastructure and government commitment to developing the economy beyond oil through its Vision 2030, is increasingly attractive…
Dr Arunish Chawla details the policy strategies underlying the explosive prospected growth of India’s pharmaceutical sector to USD 120-150 billion by 2030, including rigorous adherence to international quality standards. Highlighting…
See our Cookie Privacy Policy Here
